BMC Infect Dis. 2013 Jul 26;13:349. doi: 10.1186/1471-2334-13-349.
The world health organization (WHO) declared tuberculosis (TB) a global emergency, mainly affecting people in sub-Saharan Africa. However there is little data about the burden of TB among adolescents. We estimated the prevalence and incidence of TB and assessed factors associated with TB among adolescents aged 12-18 years in a rural population in Uganda in order to prepare the site for phase III clinical trials with novel TB vaccines among adolescents.
In a prospective cohort study, we recruited 5000 adolescents and followed them actively, every 6 months, for 1-2 years. Participants suspected of having TB were those who had any of; TB signs and symptoms, history of TB contact or a positive tuberculin skin test (TST) of ≥10 mm. Laboratory investigations included sputum smear microscopy and culture.
Of the 5000 participants, eight culture confirmed cases of TB were found at baseline: a prevalence of 160/100,000 (95% confidence interval (CI), 69-315). There were 13 incident TB cases detected in an average of 1.1 person years: an incidence of 235/100,000 person years (95% CI, 125-402). None of the confirmed TB cases were HIV infected. Predictors for prevalent TB disease were: a history of TB contact and a cough ≥ 2 weeks at baseline and being out of school, while the only predictor for incident TB was a positive TST during follow-up.
The TB incidence among adolescents in this rural part of Uganda seemed too low for a phase III TB vaccine trial. However, the study site demonstrated capability to handle a large number of participants with minimal loss to follow-up and its suitability for future clinical trials. Improved contact tracing in TB program activities is likely to increase TB case detection among adolescents. Future studies should explore possible pockets of higher TB incidence in urban areas and among out of school youth.
世界卫生组织(WHO)宣布结核病(TB)为全球紧急情况,主要影响撒哈拉以南非洲地区的人民。然而,关于青少年结核病负担的数据很少。我们评估了乌干达农村地区 12-18 岁青少年中结核病的患病率和发病率,并评估了与青少年结核病相关的因素,以便为青少年新型结核病疫苗的 III 期临床试验做准备。
在一项前瞻性队列研究中,我们招募了 5000 名青少年,并在 1-2 年内每 6 个月对他们进行主动随访。疑似患有结核病的参与者包括有以下任何一种情况的人:结核病的体征和症状、结核病接触史或结核菌素皮肤试验(TST)阳性≥10mm。实验室检查包括痰涂片显微镜检查和培养。
在 5000 名参与者中,基线时有 8 例经培养证实的结核病病例:患病率为 160/100000(95%置信区间(CI),69-315)。平均 1.1 人年中发现 13 例新发结核病病例:发病率为 235/100000 人年(95%CI,125-402)。确诊的结核病病例中没有 HIV 感染者。现患结核病的预测因素为:基线时有结核病接触史和咳嗽≥2 周以及失学,而唯一的新发结核病预测因素是随访期间 TST 阳性。
乌干达农村地区青少年的结核病发病率似乎太低,不适合进行 III 期结核病疫苗试验。然而,该研究地点证明有能力处理大量参与者,且失访率极低,适合未来的临床试验。在结核病规划活动中加强接触者追踪,可能会增加青少年结核病病例的检出率。未来的研究应探讨城市地区和失学青年中可能存在更高结核病发病率的潜在区域。